Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Hypothyroidism Treatments
US$ 1,195.00
This study covers the world outlook for hypothyroidism treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
288 pages
The 2027-2032 World Outlook for Iloprost Drugs
US$ 1,195.00
This study covers the world outlook for iloprost drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Immunology Drugs
US$ 1,195.00
This study covers the world outlook for immunology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
The 2027-2032 World Outlook for Immunology Therapeutics
US$ 1,195.00
This study covers the world outlook for immunology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
288 pages
The 2027-2032 World Outlook for Immunomodulators
US$ 1,195.00
This study covers the world outlook for immunomodulators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
The 2027-2032 World Outlook for Immunosuppressant Drugs
US$ 1,195.00
This study covers the world outlook for immunosuppressant drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Immunosuppressants
US$ 1,195.00
This study covers the world outlook for immunosuppressants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for In-Vitro Toxicity Testing
US$ 1,195.00
This study covers the world outlook for in-vitro toxicity testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for In Vivo Toxicology
US$ 1,195.00
This study covers the world outlook for in vivo toxicology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Infectious Disease Drugs
US$ 1,195.00
This study covers the world outlook for infectious disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
288 pages
The 2027-2032 World Outlook for Infectious Disease Vaccines
US$ 1,195.00
This study covers the world outlook for infectious disease vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
287 pages
The 2027-2032 World Outlook for Infertility Drugs
US$ 1,195.00
This study covers the world outlook for infertility drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Influenza Drugs
US$ 1,195.00
This study covers the world outlook for influenza drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Influenza Medications
US$ 1,195.00
This study covers the world outlook for influenza medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Inhalable Drugs
US$ 1,195.00
This study covers the world outlook for inhalable drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Inhaled Nitric Oxides
US$ 1,195.00
This study covers the world outlook for inhaled nitric oxides across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Injectable Diabetes Drugs
US$ 1,195.00
This study covers the world outlook for injectable diabetes drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Insomnia
US$ 1,195.00
This study covers the world outlook for insomnia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the cou...
January 2026
287 pages
The 2027-2032 World Outlook for Insomnia Drugs
US$ 1,195.00
This study covers the world outlook for insomnia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Insomnia Therapeutics
US$ 1,195.00
This study covers the world outlook for insomnia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Interleukin Inhibitors
US$ 1,195.00
This study covers the world outlook for interleukin inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Intravenous Immunoglobulins
US$ 1,195.00
This study covers the world outlook for intravenous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Iron Deficiency Anemia Drugs
US$ 1,195.00
This study covers the world outlook for iron deficiency anemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Iron Drugs
US$ 1,195.00
This study covers the world outlook for iron drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Joint Pain Injections
US$ 1,195.00
This study covers the world outlook for joint pain injections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Kidney Cancer Drugs
US$ 1,195.00
This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Kinase Inhibitors
US$ 1,195.00
This study covers the world outlook for kinase inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Krabbe Disease Treatments
US$ 1,195.00
This study covers the world outlook for Krabbe disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Laxatives
US$ 1,195.00
This study covers the world outlook for laxatives across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages
The 2027-2032 World Outlook for Leukemia Treatments
US$ 1,195.00
This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Life Science Products
US$ 1,195.00
This study covers the world outlook for life science products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
288 pages
